Seeking Alpha

Navidea Biopharmaceuticals (NAVB +4.7%) trades up today after reporting results of its 2013...

Navidea Biopharmaceuticals (NAVB +4.7%) trades up today after reporting results of its 2013 Annual Meeting of Stockholders held earlier today. NAVB made a series of presentations to shareholders highlighting Lymphoseek's U.S commercialization and indication expansion development activities, selection of a specialty pharma partner for its commercialization in Europe, and initiation of a pivotal NAV4694 Phase 3 registration study.
Comments (4)
  • jonnie14
    , contributor
    Comments (87) | Send Message
     
    Why is this stock not taking off?
    27 Jun 2013, 08:55 PM Reply Like
  • joelkatz
    , contributor
    Comments (448) | Send Message
     
    Patience.
    28 Jun 2013, 10:25 AM Reply Like
  • garyg77
    , contributor
    Comments (2) | Send Message
     
    agree with Joel. $5 before the end of the year.
    1 Jul 2013, 05:53 PM Reply Like
  • Indianalar
    , contributor
    Comments (5) | Send Message
     
    Plenty of effort by stronger hands.
    24 Sep 2013, 12:08 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|